Hyku Biosciences
Pre-clinicalHyku Biosciences is developing the next generation of small molecule medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Founded
2018
Focus
Small Molecules
About
Hyku Biosciences is developing the next generation of small molecule medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Funding History
1Total raised: $4.2M
Seed$4.2MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile